Showing results (1-10 of 150) with videos related to
Sort By:
Pageof 15
Medicina (Kaunas, Lithuania)|April 28, 2023
Changes in the Global Epidemiology of Type 1 Diabetes in an Evolving Landscape of Environmental Factors: Causes, Challenges, and OpportunitiesIoannis Ogrotis, Theocharis Koufakis, Kalliopi KotsaMaturitas|December 14, 2020
Type 2 diabetes management in people aged over seventy-five years: targets and treatment strategiesTheocharis Koufakis, Maria Grammatiki, Kalliopi KotsaMedicina (Kaunas, Lithuania)|November 25, 2023
Epidemiological, Pathophysiological, and Clinical Considerations on the Interplay between Thyroid Disorders and Type 2 Diabetes MellitusGregory Grigoriadis, Theocharis Koufakis, Kalliopi KotsaMinerva Endocrinologica|April 18, 2019
Emerging incretin hormones actions: focus on bone metabolismMaria Grammatiki, Vasiliki Antonopoulou, Kalliopi KotsaJournal of Integrative Medicine|April 17, 2022
Remission of type 2 diabetes depends on prompt comprehensive lifestyle changes upon diagnosis: How can this "Road to Damascus" experience be supported?Theocharis Koufakis, Kalliopi Kotsa, Nikolaos PapanasDiabetic Medicine : a Journal of the British Diabetic Association|December 11, 2020
Treating latent autoimmune diabetes in adults in the era of cardiovascular outcomes trials: Old dog should learn new tricksTheocharis Koufakis, Prashanth Vas, Kalliopi KotsaHormones (Athens, Greece)|September 27, 2018
The role of vitamin D in the pathogenesis and treatment of diabetes mellitus: a narrative reviewMaria Grammatiki, Spiros Karras, Kalliopi KotsaAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 16, 2022
A Horse, a Jockey, and a Therapeutic Dilemma: Choosing the Best Option for a Patient with Diabetes and Coronary Artery DiseaseTheocharis Koufakis, Evangelos N Liberopoulos, Kalliopi KotsaHormones (Athens, Greece)|July 10, 2015
Primary hyperparathyroidism and the road to surgery: appraisal of the proceedings of the four international workshops (1990, 2002, 2008, 2014) on primary hyperparathyroidismRomanos Sklavenitis-Pistofidis, Ourania Papaioannou, Kalliopi KotsaCancers|October 14, 2022
How Far beyond Diabetes Can the Benefits of Glucagon-like Peptide-1 Receptor Agonists Go? A Review of the Evidence on Their Effects on Hepatocellular CarcinomaKonstantinos Arvanitakis, Theocharis Koufakis, Kalliopi Kotsa, et al.Pageof 15